Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

Overview of attention for article published in Cancer Management and Research, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea

Article in Thoracic Cancer (January 2024)

Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review

Article in Cancers (October 2023)

Adverse Side Effects of Crizotinib in the Treatment of Anaplastic Lymphoma Kinase-Mutated Non-small Cell Lung Cancer: A Systematic Review

Article in Cureus (September 2023)